{'output': [['Allergan Plc', 'COMP', 'Cut', 'over 1,000 jobs', 'GPE'], ['Allergan Plc', 'COMP', 'Eliminate', '400 currently open positions', 'GPE'], ['Allergan Plc', 'COMP', 'Works_To_Cut_Costs', 'face of new competition', 'CONCEPT'], ['Allergan Plc', 'COMP', 'Operate_In', 'New York', 'GPE'], ['Allergan Plc', 'COMP', 'Has', 'Restasis', 'PRODUCT'], ['Restasis', 'PRODUCT', 'Generates', '$1.5 billion', 'ECON_INDICATOR'], ['Allergan Plc', 'COMP', 'Strike', 'a controversial deal', 'CONCEPT'], ['Allergan Plc', 'COMP', 'Shield', 'review of the patents', 'CONCEPT'], ['Allergan Plc', 'COMP', 'Draw', 'the ire of lawmakers', 'PERSON'], ['Allergan Plc', 'COMP', 'Rival_Drug_Companies', 'CONCEPT'], ['Allergan Plc', 'COMP', 'Invalidated', 'Restasis patents', 'PRODUCT'], ['Restasis', 'PRODUCT', 'Invalidated', 'on grounds that they cover ideas that are obvious', 'CONCEPT'], ['Allergan Plc', 'COMP', 'Appeal', 'the ruling', 'CONCEPT'], ['Allergan Plc', 'COMP', 'Employs', '18,000 people', 'GPE'], ['Allergan Plc', 'COMP', 'Analysts_Estimated', '$5.8 billion', 'ECON_INDICATOR'], ['Allergan Plc', 'COMP', 'Cost_Savings', '$300 million to $400 million per year', 'ECON_INDICATOR'], ['Allergan Plc', 'COMP', 'Randall Stanicky', 'PERSON'], ['Randall Stanicky', 'PERSON', 'Said', 'the savings should add around 75 cents to $1 of earnings per share support', 'CONCEPT'], ['Allergan Plc', 'COMP', 'Working_On', 'a program to expand its base business and reduce costs', 'CONCEPT'], ['Allergan Plc', 'COMP', 'Return', 'to earnings growth by 2019', 'TIME'], ['Allergan Plc', 'COMP', 'Strike', 'a controversial deal with a Native American tribe', 'GPE'], ['Allergan Plc', 'COMP', 'Draw', 'the ire of lawmakers and rival drug companies', 'PERSON'], ['Shares of Allergan', 'FIN_INSTRUMENT', 'Rise', '$1.02', 'ECON_INDICATOR'], ['Shares of Allergan', 'FIN_INSTRUMENT', 'Trade', 'at $171.34', 'ECON_INDICATOR']]}